Glutamine synthetase facilitates cancer cells to recover from irradiation-induced G2/M arrest. Issue 1 (2nd January 2020)

• Record Type: Journal Article
• Authors: Peng, Yanni; Fu, Shujun; Hu, Wenfeng; Qiu, Yanfang; Zhang, Lu; Tan, Rong; Sun, Lun-Quan
• Is Part Of: Cancer biology & therapy. Volume 21:Issue 1(2020)
• Page Start: 43
• Page End: 51
• Publication Date: 2020-01-02
• Subjects: GS -- CDK1 -- Cyclin B1 -- cell cycle -- radioresistance; 616.99406
• DOI: 10.1080/15384047.2019.1665394
• Languages: English
• ISSNs: 1538-4047

Abstract

ABSTRACT: Resistance to radiation of cancer cells can be either intrinsic or acquired, leading to treatment failure. In response to DNA damage caused by IR, cancer cells are arrested in cell cycle showing limited proliferation and increased apoptosis. However, radiation-resistant cells are able to overcome the cell cycle block and proceed to proliferation, for which the detailed mechanism remains to be elucidated. In the present study, we showed that radioresistant cells exhibited a recoverable G2/M phase during prolonged cell cycle and manifested lower apoptosis rate and more colony formation. RNA-seq analysis revealed that glutamine synthetase (GS, GLUL) gene was highly expressed in radioresistant cancer cells in comparison with the parental cells, which was in accordance with the G2/M arrest after ionizing radiation. Knocking out of GS in radioresistant cells resulted in a delayed G2/M recovery and lowered proliferation rate after ionizing radiation treatment, which was accompanied with increased inhibitory phosphorylation of CDK1 at Y15 and downregulated Cdc25B, a dual specific phosphatase of CDK1. Moreover, there was an enhanced complex formation of CDK1 and Cyclin B1 when the cells were rescued by re-introducing GS. In vivo, knocking down of GS significantly sensitized CNE2-R xenografts to RT in mice. In this study, we demonstrate a novel role of glutamine synthetase independent of metabolic function in promoting recovery from G2/M arrest caused by ionizing radiation, thus, causing cancer cell resistance to radiotherapy.